Anticoccidial Drugs Market Size, Share and Forecast (2019-2026)

SKU: DPH102 | Last Updated On: 2019-08-27 | No. of Pages: 198 | Available Formats

( 32 Samples have been requested. )
In April 2019, Creative Diagnostics has announced the launch of a series of innovative anticoccidial drug analysis services and products

Market Overview

The global anticoccidial drugs market size was worth $ XX billion in 2018 and is forecasted to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period. Coccidiosis is one of the most  prevalent parasitic diseases of domesticated animals, and its symptoms include weight loss, mild intermittent to severe diarrhea, and feces containing blood or mucus, dehydration, and reduced breeding. Coccidiosis is usually caused by single-celled parasites (protozoa) called Eimeria, which undergo a simple life cycle in the gut. Anticoccidial drugs play an essential role in the prevention and treatment of coccidiosis. Thus, the increasing incidences of coccidiosis are giving the key players lucrative opportunities to manufacture the anticoccidial drugs over the period of forecast.

Global Anticoccidial Drugs Market Value (USD Mn), 2018-2026

Market Dynamics

The increased incidence of coccidiosis drives global anticoccidial drugs market growth in food-producing animals, and companion animals, advancements in veterinary healthcare, innovative animal healthcare product launches have also gained popularity, especially in the companion animals sector, the worldwide increase in demand for proteins.
Innovative animal healthcare products are expected to boost the market over the period of forecast. For instance, in April 2019 Creative Diagnostics has announced the launch of a series of innovative anticoccidial drug analysis services and products for its global clients.
The trends of owing companion animals which is responsible for the increased demand for anticoccidial drugs as dogs, cats and occasionally even horses are prone to coccidiosis, and if left untreated it could lead to the death of the animal. An increase in the expenditure on companion animals coupled with advancements in medicines, and product launches have fueled the demand in the market. For instance, IDEXX has launched various diagnostic products and rapid kits between January 2014 and February 2019.
Increased demand for animal proteins is expected to boost the market over the period of forecast. This is owing to the tremendous population growth, which also increased the export of meat, indirectly increasing the demand for veterinary healthcare. For instance, according to the WHO, there is an increasing pressure on the livestock sector to meet the raising demand for high-value animal protein. The world's livestock sector is increasing at a huge rate, and the driving force behind this enormous increase is a combination of population growth, rising incomes, and urbanization. Also, the annual meat production is projected to increase from 218 million tonnes in 1997-1999 to 376 million tonnes by 2030. The UN Food and Agriculture Organization, has estimated that by 2050, there will be a 73% increase in meat and egg consumption and a 58% increase in dairy consumption over 2011 levels. According to Boehringer Ingelheim by 2050, the global population will reach 9.7 billion people, with a significant increase in the middle class, and substantial growth in emerging markets like Africa and Asia. As a result, the demand for animal protein is expected to increase by 70 percent.
However, the availability of alternative treatment options in the market, the massive money in the treatment and prevention of coccidiosis, growing resistance of the pathogens are expected to restrain the market growth. 
Growing number of  regulations and bans on the use of anticoccidial drugs along with the related costs in developing new drugs  increase the need for the development of novel approaches and alternative control strategies for coccidiosis. For instance, the use of alternative treatments such as vaccines, herbal remedies, homeopathy, phytotherapy, and aromatherapy to treat coccidiosis is likely to restrain the growth of anticoccidial drugs market across the world. Resistance has been documented for all those of the drugs currently employed, and therefore the discovery of novel drugs with unique modes of action is imperative if chemotherapy is to remain the principal means to control this disease.
Global Anticoccidial Drugs Market Segment Analysis
Based on drug type, the global anticoccidial drugs market is segmented into Ionophore Anticoccidials, Chemical Derivative Anticoccidials.
Ionophore anticoccidial segment is expected to boost the market. For instance, a significant breakthrough in the prevention of coccidiosis through the feed medication  in 1972, with the initial launch of the first polyether ionophore anticoccidial, known as monensin. Ionophores are  fermentation products of Streptomyces and other fungi species; and are the most widely used drugs for coccidiosis prevention due to its broad-spectrum activity against the majority of pathogenic species of coccidians. In 2017, the US FDA reported that 82% of all domestic sales and distribution of non-medically important antimicrobials are from ionophores, costing to 4,394,850 kg.  Due to the factors mentioned above, the ionophore anticoccidial segment is expected to experience healthy growth during the forecast period.

Global Market Share of Anticoccidial Drugs Market (%), By  Drug Type

Based on animal type, the global anticoccidial drugs market is segmented into poultry, swine, and others. The global poultry industry is considered most affected by coccidiosis as it causes the annual industry loss that has been estimated to exceed US$ 3 billion per year. According to the Agricultural Economics Research in 2010, in India, reported that the commercial broiler industry is a significant sufferer due to coccidiosis wherein 95.61 % of the total economic loss occurs due to the disease. Poultry production is projected to increase, and the control of coccidiosis will be essential if poultry and livestock meat is to fulfill the increasing need for protein by the growing world population. The presence of various vital players manufacturing anticoccidial drugs for poultry are expected to drive the market — for instance, Bayer's Baycox 2.5% for coccidiosis control and treatment of poultry. Huvepharma’s Amprol® 25% feed premix (amprolium) is used for the prevention and treatment of coccidiosis in broilers, replacements, turkeys, layers, and pheasants. The animals include chicken, dogs, birds, cattle, goat, etc., 
Global Anticoccidial Drugs Market Geographical Analysis
North America is dominating the global anticoccidial drugs market in 2018 and estimated to hold largest market size over the forecast period (2019-2026). This is owing to the availability of anticoccidial drugs, awareness for the prevention of coccidiosis, safe animal food supply, and high investment in R&D in developing novel products are likely to propel the North America Anticoccidial Drugs market during the forecast period.
According to the USDA Economic Research Service, the poultry sector is the fastest-growing in the meat product market in the US. The size of the poultry segment was around US$ 56 Mn. 
The raised consumption of meat is expected to accelerate the anticoccidial drugs market in North America. For instance, according to the North American meat institute, the meat and poultry industry is the largest segment of U.S. agriculture. U.S. meat production totaled 52 billion pounds in 2017, and U.S. poultry production totaled 48 billion pounds in 2017.
Europe is the  significant region of the anticoccidial drugs market, owing to a highly developed health care industry, significant government funds for the development of veterinary medicines, growing awareness among people, and high consumption of meat. The Biotechnology and Biological Sciences Research Council has donated GBP 5.7 Million for the development of vaccines of poultry to the London School of Hygiene and Tropical Medicine in December 2015. 
Global Anticoccidial Drugs Market Share (%), By Geography, 2018

Competitive Landscape

Some of the major players in the global anticoccidial drugs market are Bayer Animal Healthcare, Boehringer Ingelheim, Ceva Animal Health Inc., Elanco Animal Health (a subsidiary of Eli Lilly), Merck, Merial, Virbac, Zoetis Animal Healthcare, Vetoquinol SA, and others.
The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, which are contributing to the growth of the Anticoccidial drugs market globally. For instance, 
In August 2019, Elanco Animal Health announced that it would spend $7.6 billion to acquire Bayer AG's veterinary medicines business, which would make it the second-largest animal health company.
On May 21, 2019, Merck Animal Health, Kenilworth, N.J., USA, and NEADS World Class Service Dogs had announced the launch of BRAVECTO® Cares, which is an educational campaign showcasing the critical role of dogs  and the importance of keeping them healthy, including protecting them from fleas and ticks. 
In January 2016, the Federation of Veterinarians of Europe released a position paper requesting the European Commission to update its 2008 report and to amend regulation EC 1831/2003 to require a veterinary prescription for the use of all anticoccidials.

Why Purchase the Report?
•    Visualize the composition of the global anticoccidial drugs market in terms of various drug types, and type of animals highlighting the critical commercial assets and players.
•    Identify commercial opportunities in global anticoccidial drugs market by analyzing trends and co-development deals. 
•    Excel data sheet with thousands of data points of global anticoccidial drugs market-level 4/5 segmentation.
•    A PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
•    Product mapping in excel for the key product of all major market players.


Target Audience
•    Service Providers/ Buyers
•    Industry Investors/Investment Bankers
•    Education & Research Institutes
•    Research Professionals
•    Emerging Companies
•    Manufacturers
 

  1. Global Anticoccidial Drugs Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Global Anticoccidial Drugs Market – Market Definition and Overview

  3. Global Anticoccidial Drugs Market – Executive Summary

    1. Market Snippet by Drug type
    2. Market Snippet by Animal type
  4. Global Anticoccidial Drugs Market Dynamics

    1. Market Impacting Factors
      1. Drivers
        1. The presence of innovative animal healthcare products
      2. Restraints
        1. The presence of alternative treatment options
      3. Opportunity
      4. Impact Analysis
  5. Global Anticoccidial Drugs Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Regulatory Analysis
    3. Supply Chain Analysis
    4. Pricing Analysis
  6. Global Anticoccidial Drugs Market – By Drug type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug type segment
      2. Market Attractiveness Index, By Drug type Segment
    2. Ionophore anticoccidials *
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
    3. Chemical derivative anticoccidials
  7. Global Anticoccidial Drugs Market – by Animal type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal type Segment
      2. Market Attractiveness Index, By Animal type Segment
    2. Poultry *
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026
    3. Swine
    4. Cattle
    5. Others
  8. Global Anticoccidial Drugs Market - By Region

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. The U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. The U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. The Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Animal type
  9. Global Anticoccidial Drugs Market Competitive Landscape

    1. Competitive Scenario
    2. Market Positioning/Share Analysis
    3. Mergers and Acquisitions Analysis
  10. Global Anticoccidial Drugs Market Company Profiles

    1. Bayer HealthCare *
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Boehringer Ingelheim
    3. Ceva Animal Health Inc
    4. Elanco Animal Health ( a subsidiary of Eli Lilly)
    5. Merck
    6. Merial
    7. Virbac
    8. Zoetis Animal Healthcare
    9. Vetoquinol SA
    10. Others
  11. Global Anticoccidial Drugs Market – Premium Insights

  12. Global Anticoccidial Drugs Market – Data M

    1. Appendix
    2. About Us and Services
    3. Contact Us

LIST OF TABLES    
TABLE 01 GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, BY DRUG TYPE, 2018,2022 & 2026 ($ MILLION)
TABLE 02 GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, BY ANIMAL TYPE, 2018,2022 & 2026 ($ MILLION)
TABLE 03 GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, BY REGION, 2018,2022 & 2026 ($ MILLION)
TABLE 04 GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, BY COUNTRY, 2018,2022 & 2026 ($ MILLION)
TABLE 05 GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, BY DRUG TYPE, 2018,2022 & 2026 ($ MILLION)
TABLE 06 GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, BY DRUG TYPE, 2017-2026 ($ MILLION)
TABLE 07 GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, BY ANIMAL TYPE, 2018,2022 & 2026 ($ MILLION)
TABLE 08 GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, BY ANIMAL TYPE, 2017-2026 ($ MILLION)
TABLE 09 GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, BY REGION, 2018,2022 & 2026 ($ MILLION)
TABLE 10 GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, BY REGION, 2017-2026 ($ MILLION)
TABLE 11 GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, BY COUNTRY, 2018,2022 & 2026 ($ MILLION)
TABLE 12 GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, BY COUNTRY, 2017-2026 ($ MILLION)
TABLE 13 NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET VALUE, BY DRUG TYPE, 2017-2026 ($ MILLION)
TABLE 14 NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET VALUE, BY ANIMAL TYPE, 2017-2026 ($ MILLION)
TABLE 15 NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET VALUE, BY REGION, 2017-2026 ($ MILLION)
TABLE 16 NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET VALUE, BY COUNTRY, 2017-2026 ($ MILLION)
TABLE 17 SOUTH AMERICA ANTICOCCIDIAL DRUGS MARKET VALUE, BY DRUG TYPE, 2017-2026 ($ MILLION)
TABLE 18 SOUTH AMERICA ANTICOCCIDIAL DRUGS MARKET VALUE, BY ANIMAL TYPE, 2017-2026 ($ MILLION)
TABLE 19 SOUTH AMERICA ANTICOCCIDIAL DRUGS MARKET VALUE, BY REGION, 2017-2026 ($ MILLION)
TABLE 20 SOUTH AMERICA ANTICOCCIDIAL DRUGS MARKET VALUE, BY COUNTRY, 2017-2026 ($ MILLION)
TABLE 21 EUROPE ANTICOCCIDIAL DRUGS MARKET VALUE, BY DRUG TYPE, 2017-2026 ($ MILLION)
TABLE 22 EUROPE ANTICOCCIDIAL DRUGS MARKET VALUE, BY ANIMAL TYPE, 2017-2026 ($ MILLION)
TABLE 23 EUROPE ANTICOCCIDIAL DRUGS MARKET VALUE, BY REGION, 2017-2026 ($ MILLION)
TABLE 24 EUROPE ANTICOCCIDIAL DRUGS MARKET VALUE, BY COUNTRY, 2017-2026 ($ MILLION)
TABLE 25 ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET VALUE, BY DRUG TYPE, 2017-2026 ($ MILLION)
TABLE 26 ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET VALUE, BY ANIMAL TYPE, 2017-2026 ($ MILLION)
TABLE 27 ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET VALUE, BY REGION, 2017-2026 ($ MILLION)
TABLE 28 ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET VALUE, BY COUNTRY, 2017-2026 ($ MILLION)
TABLE 29 MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET VALUE, BY DRUG TYPE, 2017-2026 ($ MILLION)
TABLE 30 MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET VALUE, BY ANIMAL TYPE, 2017-2026 ($ MILLION)
TABLE 31 MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET VALUE, BY REGION, 2017-2026 ($ MILLION)
TABLE 32 MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET VALUE, BY COUNTRY, 2017-2026 ($ MILLION)
TABLE 33 BAYER HEALTHCARE: OVERVIEW  
TABLE 34 BAYER HEALTHCARE: PRODUCT PORTFOLIO  
TABLE 35 BAYER HEALTHCARE: KEY DEVELOPMENTS  
TABLE 36 BOEHRINGER INGELHEIM : OVERVIEW  
TABLE 37 BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO 
TABLE 38 BOEHRINGER INGELHEIM: KEY DEVELOPMENTS 
TABLE 39 CEVA ANIMAL HEALTH INC: OVERVIEW  
TABLE 40 CEVA ANIMAL HEALTH INC: PRODUCT PORTFOLIO 
TABLE 41 CEVA ANIMAL HEALTH INC: KEY DEVELOPMENTS 
TABLE 42 ELANCO ANIMAL HEALTH: OVERVIEW  
TABLE 43 ELANCO ANIMAL HEALTH: PRODUCT PORTFOLIO 
TABLE 44 ELANCO ANIMAL HEALTH: KEY DEVELOPMENTS 
TABLE 45 MERCK: OVERVIEW    
TABLE 46 MERCK: PRODUCT PORTFOLIO   
TABLE 47 MERCK: KEY DEVELOPMENTS   
TABLE 48 MERIAL: OVERVIEW   
TABLE 49 MERIAL: PRODUCT PORTFOLIO   
TABLE 50 MERIAL: KEY DEVELOPMENTS   
TABLE 51 VIRBAC: OVERVIEW   
TABLE 52 VIRBAC: PRODUCT PORTFOLIO   
TABLE 53 VIRBAC: KEY DEVELOPMENTS   
TABLE 54 ZOETIS ANIMAL HEALTHCARE: OVERVIEW  
TABLE 55 ZOETIS ANIMAL HEALTHCARE: PRODUCT PORTFOLIO 
TABLE 56 ZOETIS ANIMAL HEALTHCARE: KEY DEVELOPMENTS 
TABLE 57 VETOQUINOL SA: OVERVIEW   
TABLE 58 VETOQUINOL SA: PRODUCT PORTFOLIO  
TABLE 59 VETOQUINOL SA: KEY DEVELOPMENTS  
TABLE 60 OTHERS: OVERVIEW   
TABLE 61 OTHERS: PRODUCT PORTFOLIO   
TABLE 62 OTHERS: KEY DEVELOPMENTS   
 

LIST OF FIGURES   
FIGURE 01 GLOBAL ANTICOCCIDIAL DRUGS MARKET SHARE, BY DRUG TYPE, 2018 & 2026 (%)
FIGURE 02 GLOBAL ANTICOCCIDIAL DRUGS MARKET SHARE, BY ANIMAL TYPE, 2018 & 2026 (%)
FIGURE 03 GLOBAL ANTICOCCIDIAL DRUGS MARKET SHARE, BY REGION, 2018 & 2026 (%)
FIGURE 04 GLOBAL ANTICOCCIDIAL DRUGS MARKET SHARE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 05 GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, 2017-2026 ($ MILLION)
FIGURE 06 GLOBAL ANTICOCCIDIAL DRUGS MARKET Y-O-Y GROWTH, BY DRUG TYPE, 2018-2026 (%)
FIGURE 07 IONOPHORE ANTICOCCIDIALS: GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, 2017-2026 ($ MILLION)
FIGURE 08 CHEMICAL DERIVATIVE ANTICOCCIDIALS: GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, 2017-2026 ($ MILLION)
FIGURE 09 GLOBAL ANTICOCCIDIAL DRUGS MARKET Y-O-Y GROWTH, BY ANIMAL TYPE, 2018-2026 (%)
FIGURE 10 POULTRY: GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, 2017-2026 ($ MILLION)
FIGURE 11 SWINE: GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, 2017-2026 ($ MILLION)
FIGURE 12 OTHERS: GLOBAL ANTICOCCIDIAL DRUGS MARKET VALUE, 2017-2026 ($ MILLION)
FIGURE 13 GLOBAL ANTICOCCIDIAL DRUGS MARKET Y-O-Y GROWTH, BY REGION, 2018-2026 (%)
FIGURE 14 GLOBAL ANTICOCCIDIAL DRUGS MARKET Y-O-Y GROWTH, BY COUNTRY, 2018-2026 (%)
FIGURE 15 NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET VALUE, 2017-2026 ($ MILLION)
FIGURE 16 NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SHARE, BY DRUG TYPE, 2018 & 2026 (%)
FIGURE 17 NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SHARE, BY ANIMAL TYPE, 2018 & 2026 (%)
FIGURE 18 NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SHARE, BY REGION, 2018 & 2026 (%)
FIGURE 19 NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SHARE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 20 SOUTH AMERICA ANTICOCCIDIAL DRUGS MARKET VALUE, 2017-2026 ($ MILLION)
FIGURE 21 SOUTH AMERICA ANTICOCCIDIAL DRUGS MARKET SHARE, BY DRUG TYPE, 2018 & 2026 (%)
FIGURE 22 SOUTH AMERICA ANTICOCCIDIAL DRUGS MARKET SHARE, BY ANIMAL TYPE, 2018 & 2026 (%)
FIGURE 23 SOUTH AMERICA ANTICOCCIDIAL DRUGS MARKET SHARE, BY REGION, 2018 & 2026 (%)
FIGURE 24 SOUTH AMERICA ANTICOCCIDIAL DRUGS MARKET SHARE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 25 EUROPE ANTICOCCIDIAL DRUGS MARKET VALUE, 2017-2026 ($ MILLION)
FIGURE 26 EUROPE ANTICOCCIDIAL DRUGS MARKET SHARE, BY DRUG TYPE, 2018 & 2026 (%)
FIGURE 27 EUROPE ANTICOCCIDIAL DRUGS MARKET SHARE, BY ANIMAL TYPE, 2018 & 2026 (%)
FIGURE 28 EUROPE ANTICOCCIDIAL DRUGS MARKET SHARE, BY REGION, 2018 & 2026 (%)
FIGURE 29 EUROPE ANTICOCCIDIAL DRUGS MARKET SHARE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 30 ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET VALUE, 2017-2026 ($ MILLION)
FIGURE 31 ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SHARE, BY DRUG TYPE, 2018 & 2026 (%)
FIGURE 32 ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SHARE, BY ANIMAL TYPE, 2018 & 2026 (%)
FIGURE 33 ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SHARE, BY REGION, 2018 & 2026 (%)
FIGURE 34 ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SHARE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 35 MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET VALUE, 2017-2026 ($ MILLION)
FIGURE 36 MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SHARE, BY DRUG TYPE, 2018 & 2026 (%)
FIGURE 37 MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SHARE, BY ANIMAL TYPE, 2018 & 2026 (%)
FIGURE 38 MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SHARE, BY REGION, 2018 & 2026 (%)
FIGURE 39 MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SHARE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 40 BAYER HEALTHCARE: FINANCIALS 
FIGURE 41 BOEHRINGER INGELHEIM : FINANCIALS 
FIGURE 42 CEVA ANIMAL HEALTH INC: FINANCIALS 
FIGURE 43 ELANCO ANIMAL HEALTH: FINANCIALS 
FIGURE 44 MERCK: FINANCIALS  
FIGURE 45 MERIAL: FINANCIALS  
FIGURE 46 VIRBAC: FINANCIALS  
FIGURE 47 ZOETIS ANIMAL HEALTHCARE: FINANCIALS 
FIGURE 48 VETOQUINOL SA: FINANCIALS  
FIGURE 49 OTHERS: FINANCIALS  

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
step 1We collate your requirements.
step 2Our global research team is put into action.
step 3We deliver, and make sure your endeavour is a success!

Buy This Report